Literature DB >> 15554237

Glutathione-dependent bioactivation of haloalkanes and haloalkenes.

M W Anders1.   

Abstract

Haloalkanes and haloalkenes constitute an important group of widely used chemicals that have the potential to induce toxicity and cancer. The toxicity of haloalkanes and haloalkenes may be associated with cytochromes P450- or glutathione transferase-dependent bioactivation. This review is concerned with the glutathione- and glutathione transferase-dependent bioactivation of dihalomethanes, 1,2-dihaloalkanes, and haloalkenes. Dihalomethanes, e.g., dichloromethane, and 1,2-dihaloethanes, e.g., 1,2-dichloroethane and 1,2-dibromoethane, undergo glutathione transferase-catalyzed bioactivation to give S-(halomethyl)glutathione or glutathione episulfonium ions, respectively, as reactive intermediates. Haloalkenes, e.g., trichloroethene, hexachlorobutadiene, chlorotrifluoroethene, and tetrafluoroethene, undergo cysteine conjugate beta-lyase-dependent bioactivation to thioacylating intermediates, including thioacyl halides, thioketenes, and 2,2,3-trihalothiiranes. With all of these compounds, the formation of reactive intermediates is associated with their observed toxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15554237     DOI: 10.1081/dmr-200033451

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  9 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

2.  Kynurenine aminotransferase III and glutamine transaminase L are identical enzymes that have cysteine S-conjugate β-lyase activity and can transaminate L-selenomethionine.

Authors:  John T Pinto; Boris F Krasnikov; Steven Alcutt; Melanie E Jones; Thambi Dorai; Maria T Villar; Antonio Artigues; Jianyong Li; Arthur J L Cooper
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

3.  Ile105Val GSTP1 polymorphism and susceptibility to colorectal carcinoma in Bulgarian population.

Authors:  Tatyana Vlaykova; Lyuba Miteva; Maya Gulubova; Spaska Stanilova
Journal:  Int J Colorectal Dis       Date:  2007-04-03       Impact factor: 2.571

Review 4.  Cysteine S-conjugate β-lyases: important roles in the metabolism of naturally occurring sulfur and selenium-containing compounds, xenobiotics and anticancer agents.

Authors:  Arthur J L Cooper; Boris F Krasnikov; Zoya V Niatsetskaya; John T Pinto; Patrick S Callery; Maria T Villar; Antonio Artigues; Sam A Bruschi
Journal:  Amino Acids       Date:  2010-03-22       Impact factor: 3.520

5.  Measurement of cysteine S-conjugate β-lyase activity.

Authors:  Arthur J L Cooper; Boris F Krasnikov; John T Pinto; Sam A Bruschi
Journal:  Curr Protoc Toxicol       Date:  2010-05

Review 6.  Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence.

Authors:  Edward A Lock; Jing Zhang; Harvey Checkoway
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-07       Impact factor: 4.219

7.  Covalent cross-linking of glutathione and carnosine to proteins by 4-oxo-2-nonenal.

Authors:  Xiaochun Zhu; Molly M Gallogly; John J Mieyal; Vernon E Anderson; Lawrence M Sayre
Journal:  Chem Res Toxicol       Date:  2009-06       Impact factor: 3.739

8.  Editor's Highlight: High-Throughput Functional Genomics Identifies Modulators of TCE Metabolite Genotoxicity and Candidate Susceptibility Genes.

Authors:  Vanessa Y De La Rosa; Jonathan Asfaha; Michael Fasullo; Alex Loguinov; Peng Li; Lee E Moore; Nathaniel Rothman; Jun Nakamura; James A Swenberg; Ghislaine Scelo; Luoping Zhang; Martyn T Smith; Chris D Vulpe
Journal:  Toxicol Sci       Date:  2017-11-01       Impact factor: 4.849

9.  Combining In Vivo Data with In Silico Predictions for Modeling Hepatic Steatosis by Using Stratified Bagging and Conformal Prediction.

Authors:  Sankalp Jain; Ulf Norinder; Sylvia E Escher; Barbara Zdrazil
Journal:  Chem Res Toxicol       Date:  2020-12-21       Impact factor: 3.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.